Login to Your Account


'WE SHOULD LOOK AT OPPORTUNITIES'

LONDON – Work starts Monday on drawing up a life sciences transition program that the industry intends to present to government on Sept. 6 as a blueprint for negotiating the U.K.'s exit from the EU on favorable terms for the sector.

more »

Our Habitat for All Things Science
Monitoring, surveillance, cutting inappropriate use can slow brewing crisis

As its genesis so potently illustrates, the rise of antimicrobial resistance (AMR) will not be defused by an antibiotics arms race against the superbug.

Yes, new antibiotics form part of the answer, but work is needed in other areas and sectors to ensure the effectiveness of existing and novel drugs is maintained.

With resistant bacteria emerging in humans, animals and the environment – and spreading from one compartment to another – there is no geographical frontier or human/animal barrier.

READ MORE »

Opinion


Partners in Focus